Welcome to CaliforniaLifeScience.com
CaliforniaLifeScience.com is part of a specialized network of state based biotechnology, medical device,
and life science sites that includes more than 3,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
More...
|
|
Learn About California's BioHistory
Why is there a biotechnology industry in California? Will the industry continue
to grow in California? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through California BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of California.
More CA BioHistory...
|
Local News...
Free News Release Posting & Archiving Service
- Insecticide Movento(R) approved in United States and Canada The new insecticidal active ingredient spirotetramat from Bayer CropScience has been granted regulatory approval in the strategically important markets in the United States and Canada. Spirotetramat will be marketed worldwide under the brand name Movento(R).
Bayer July 03, 2008
- Wyeth and Progenics receive approval from European Commission for RELISTOR Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission.
Progenics Pharmaceuticals, Inc. July 03, 2008
- Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The lead therapeutic candidate is expected to enter Phase 1 clinical testing in 3Q 2008.
Bayer July 02, 2008
- Sequenom launches iSEQ application Sequenom announced the launch of the iSEQ(TM) application software, a MassARRAY(R) comparative sequence analysis application for automated, high-throughput identification and typing of microbes and viruses, as well as human disease-related molecular markers.
Sequenom, Inc. July 02, 2008
- Sequenom announces exercise in full of underwriters' option to purchase additional shares Sequenom announced that the underwriters of its previously announced common stock offering that priced on June 25, 2008 have exercised in full an option to purchase an additional 825,000 shares of its common stock.
Sequenom, Inc. July 02, 2008
More... | Submit News Release | National News
|